The Centers for Disease Control and Prevention (CDC) plays a major role protecting the public health and safety of all citizens from disease threats, including infectious diseases. CDC addresses antimicrobial resistance, responds to outbreaks of vaccine preventable diseases, and aims to ensure that global epidemics of emerging diseases do not reach our shores.
CDC Funding – Congressional Environment
- While the FY2017 omnibus funding bill provided some increases in CDC funding, the Trump administration’s FY2018 budget proposes deep reductions, including cuts to antimicrobial resistance programs, immunization, HIV/AIDS, and global health programs.
- Congress is now determining FY2018 funding levels for CDC programs. It is vital that members of Congress understand the importance of robust CDC funding. IDSA urges Congress to reject these cuts and provide full FY2018 funding for CDC’s ID/HIV programs.
- Include personal stories and background about the importance of CDC programs to your work, your patients and your community.
FY2018 CDC Funding Appropriations Asks
- *Antibiotic Resistance Solutions Initiative ($200 million):* Congress should fully fund the Initiative at $200 million in FY2018. This level of funding would expand AR prevention efforts to all 50 states, six large cities, and Puerto Rico to reduce the emergence and spread of AR pathogens and improve appropriate antibiotic use. Congress should reject the administration’s proposal to shift its funding into the Prevention and Public Health Fund, which is in danger of repeal, putting all of this initiative’s funding at risk.
- Healthcare-Associated Infections (HAIs) ($12 million): Funding of $12 million in FY2018 would support efforts in every state to reduce the incidence of some HAIs, including those caused by antimicrobial pathogens by eliminating funding for the HAI program. Congress should continue to invest in this program so that state, local, and territorial health departments can respond to HAIs.
- National Healthcare Safety Network ($21 million): Funding of $21 million in FY2018 would enhance NHSN reporting at more than 20,000 healthcare facilities, including acute-care hospitals, dialysis facilities, nursing homes and ambulatory surgical centers, and enable CDC to continue to provide data for national HAI elimination. Funding will also increase the number of facilities reporting antibiotic use and resistance data.
- Advanced Molecular Detection Initiative ($30 million): Funding of $30 million for AMD would allow CDC to more rapidly determine where emerging diseases come from, whether microbes are resistant to antibiotics, and how microbes are moving through a population. The AMD strengthens CDC’s epidemiologic and laboratory expertise to effectively guide public health action.
- The Immunization Grant Program (Section 317) ($611 million): $611 million in funding for the Section 317 program would allow providers to obtain and store vaccines; establish and maintain vaccine registries, and educate the public about the importance of vaccines. The program helps decrease the number of adults who die each year from vaccine-preventable illnesses, and helps prevent outbreaks of diseases due to inadequate vaccinations rates, such as the recent spread of measles in Minnesota.
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention ($1.285 billion): Congress should provide robust funding of $1.285 billion for the Center so that CDC can continue to address HIV/AIDS, the growing number of syphilis cases, and increases in hepatitis and tuberculosis.
- CDC Global Health ($427 million): Funding of $427 million for the Global Health Program would help protect Americans by strengthening health capacity and improving health outcomes globally. The funding would support the global HIV program, which, as a key implementer of PEPFAR, facilitates access to life-saving antiretroviral treatment for millions, including to pregnant women living with HIV to prevent transmission to their children. Funding would also enhance the CDC’s ability to provide high quality technical support for surveillance, infection control, diagnosis and treatment of tuberculosis in 25 high burden countries. CDCs global health activities are also critical for ensuring America’s health security, with funding going toward strengthening laboratory capacities, disease surveillance and field epidemiology activities in the developing world to stop health threats overseas before they reach American soil. Congress should provide robust funding for the HIV program, global immunization, polio eradication efforts, and the global disease detection program, which detects and stops health threats at their source before they reach American shores.
- Vector-borne Diseases: Robust funding for CDC’s vector-borne disease efforts is integral in the United States response to Zika. Funding was provided to state and local health departments across the country to build capacity for Zika virus testing, surveillance, and to minimize infections in areas where there were confirmed transmissions. FY2018 funding would also support surveillance of tick-borne illnesses, and additional research to better understand how to prevent these infections.